Charles River Associates (CRA) reported a slight decrease in revenue for Q3 2023, but experienced double-digit revenue growth in Forensic Services and Life Sciences practices. The company increased its quarterly dividend by 17% despite macroeconomic uncertainty.
Revenue declined by 0.6% year-over-year to $147.6 million.
Net income decreased by 27.6% year-over-year to $8.6 million.
Earnings per diluted share decreased by 25.8% year-over-year to $1.21.
The company increased its quarterly cash dividend by 17% to $0.42 per common share.
CRA lowered its revenue and profit guidance for full-year fiscal 2023 due to macroeconomic uncertainties. The company expects revenue in the range of $610.0 million to $620.0 million and a non-GAAP EBITDA margin in the range of 10.3% to 10.7% on a constant currency basis.
Analyze how earnings announcements historically affect stock price performance